Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
0.1200
+0.0210 (21.21%)
At close: Oct 19, 2026, 4:00 PM EDT
0.1122
-0.0078 (-6.50%)
After-hours: Oct 19, 2026, 6:56 PM EDT
Adagio Medical Holdings Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
41
Market Cap
2.67M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 602.00K | 302.00K | 100.67% |
| Dec 31, 2023 | 300.00K | 111.00K | 58.73% |
| Dec 31, 2022 | 189.00K | -81.00K | -30.00% |
| Dec 31, 2021 | 270.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 20.90M |
| WORK Medical Technology Group LTD | 10.72M |
| Nuwellis | 9.01M |
| Beyond Air | 7.69M |
| INVO Fertility | 7.53M |
| Tenon Medical | 5.31M |
| VolitionRx | 2.46M |
| 20/20 Biolabs | 2.04M |
ADGM News
- 6 days ago - Adagio Medical Holdings Proxy statement: Proxy filing - Filings
- 18 days ago - Adagio Medical Holdings Proxy statement: Proxy filing - Filings
- 26 days ago - Adagio Medical announces review of strategic alternatives - TheFly
- 26 days ago - Adagio Medical Announces Strategic Review Process to Maximize Shareholder Value - Business Wire
- 4 weeks ago - Adagio Medical highlights first patient enrolled in vCLAS ULTA System - TheFly
- 4 weeks ago - Adagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS™ Ultra System for Ventricular Tachycardia at Banner – University Medical Center Phoenix - Business Wire
- 2 months ago - Adagio Medical Reports Second Quarter 2026 Results - Business Wire
- 2 months ago - Adagio Medical Holdings Quarterly report: Q2 2026 - Filings